Literature DB >> 18671304

Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.

Kouichi Miura1, Kojiro Taura, Yuzo Kodama, Bernd Schnabl, David A Brenner.   

Abstract

UNLABELLED: Chronic hepatitis C is characterized by iron accumulation in the liver, and excessive iron is hepatotoxic. However, the mechanism by which hepatitis C virus (HCV) regulates iron metabolism is poorly understood. Hepcidin plays a pivotal role as a negative regulator of iron absorption. The aim of the current study was to elucidate the mechanisms that govern hepcidin expression by HCV. Huh 7 cells, Huh7.5 cells, full-length HCV replicon cells established from Huh7.5 cells, and adenoviruses expressing HCV-core or HCV nonstructural proteins 3 through 5 (NS3-5) were used. Hepcidin expression was significantly lower in HCV replicon cells and in HCV core-expressing Huh7 cells. The expression was inversely correlated with the amount of reactive oxygen species (ROS) production. Anti-oxidants restored hepcidin expression in HCV replicon cells and Huh7 cells expressing HCV core. In HCV replicon cells, histone deacetylase (HDAC) activity was elevated at baseline and after exposure to hydrogen peroxide. Anti-oxidants reduced HDAC activity in a dose-dependent manner. HDAC inhibition increased hepcidin expression without affecting ROS production in HCV replicon cells. HCV-induced ROS stabilized the expression of two negative hepcidin regulators, HIF1alpha and HIF2alpha, and its expression was decreased by a HDAC inhibitor or an anti-oxidant. HCV-induced ROS also caused hypoacetylation of histones and inhibited binding of two positive regulators, C/EBPalpha and STAT3, to the hepcidin promoter, whereas anti-oxidant treatment of cells recovered C/EBPalpha and STAT3 binding to the hepcidin promoter. In addition, an HDAC inhibitor restored their binding to the hepcidin promoter via acetylation of histones.
CONCLUSION: HCV-induced oxidative stress suppresses hepcidin expression through increased HDAC activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18671304     DOI: 10.1002/hep.22486

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  93 in total

1.  Decreased prohepcidin levels in patients with HBV-related liver disease: relation with ferritin levels.

Authors:  Oya Yonal; Filiz Akyuz; Kadir Demir; Sevgi Ciftci; Fahriye Keskin; Binnur Pinarbasi; Ahmet Uyanikoglu; Halim Issever; Sadakat Ozdil; Gungor Boztas; Fatih Besisik; Sabahattin Kaymakoglu; Yilmaz Cakaloglu; Zeynel Mungan; Atilla Okten
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

2.  Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner.

Authors:  Wenyu Lin; Wei-Lun Tsai; Run-Xuan Shao; Guoyang Wu; Lee F Peng; Lydia L Barlow; Woo Jin Chung; Leiliang Zhang; Hong Zhao; Jae-Young Jang; Raymond T Chung
Journal:  Gastroenterology       Date:  2010-03-12       Impact factor: 22.682

Review 3.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

Review 4.  The liver: conductor of systemic iron balance.

Authors:  Delphine Meynard; Jodie L Babitt; Herbert Y Lin
Journal:  Blood       Date:  2013-11-07       Impact factor: 22.113

5.  Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.

Authors:  Pelagia Foka; Alexios Dimitriadis; Eirini Karamichali; Eleni Kyratzopoulou; Dionyssios Giannimaras; John Koskinas; Agoritsa Varaklioti; Avgi Mamalaki; Urania Georgopoulou
Journal:  Virulence       Date:  2016-04-08       Impact factor: 5.882

Review 6.  What is expected from the pathologist in the diagnosis of viral hepatitis?

Authors:  Helmut Denk
Journal:  Virchows Arch       Date:  2011-02-26       Impact factor: 4.064

Review 7.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

8.  Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: compartmentalization is critical for iron sensing.

Authors:  Alina Daba; Konstantinos Gkouvatsos; Giada Sebastiani; Kostas Pantopoulos
Journal:  J Mol Med (Berl)       Date:  2012-07-31       Impact factor: 4.599

9.  Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma.

Authors:  Masato Tsuchiya; Joel S Parker; Hiroshi Kono; Masanori Matsuda; Hideki Fujii; Ivan Rusyn
Journal:  Mol Cancer       Date:  2010-04-09       Impact factor: 27.401

10.  The role of MR imaging in detection of hepatic iron overload in patients with cirrhosis of different origins.

Authors:  Edyta Szurowska; Katarzyna Sikorska; E Izycka-Swieszewska; Tomasz Nowicki; Tomasz Romanowski; Krzysztof P Bielawski; Michał Studniarek
Journal:  BMC Gastroenterol       Date:  2010-01-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.